Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Net Cash Flow (2017 - 2026)

Inspire Medical Systems' Net Cash Flow history spans 10 years, with the latest figure at -$5.9 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow rose 93.87% to -$5.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $45.1 million, a 137.16% increase, with the full-year FY2025 number at -$45.0 million, down 27.67% from a year prior.
  • Net Cash Flow hit -$5.9 million in Q1 2026 for Inspire Medical Systems, up from -$7.8 million in the prior quarter.
  • Over the last five years, Net Cash Flow for INSP hit a ceiling of $231.4 million in Q3 2022 and a floor of -$144.6 million in Q4 2023.
  • Historically, Net Cash Flow has averaged -$6.8 million across 5 years, with a median of -$5.9 million in 2026.
  • Biggest five-year swings in Net Cash Flow: surged 587.48% in 2022 and later tumbled 1955.24% in 2024.
  • Tracing INSP's Net Cash Flow over 5 years: stood at $23.6 million in 2022, then tumbled by 712.38% to -$144.6 million in 2023, then skyrocketed by 101.94% to $2.8 million in 2024, then plummeted by 376.64% to -$7.8 million in 2025, then rose by 24.17% to -$5.9 million in 2026.
  • Business Quant data shows Net Cash Flow for INSP at -$5.9 million in Q1 2026, -$7.8 million in Q4 2025, and $5.8 million in Q3 2025.